Skip to content
Search

Latest Stories

Invatech Health donates £54,000 to fully fund a new medical centre in Northern Syria

Invatech Health donates £54,000 to fully fund a new medical centre in Northern Syria

The company’s CEO Tariq Muhammad is appealing to other UK business owners to help raise a further £125,000 to help those in desperate need in the region

Bristol-based Invatech Health has announced that it is fully funding the development of a new medical centre for families displaced by war and disaster in Northern Syria.


The company has donated £54,000 to Action for Humanity for the medical centre, which would be part of a new village being constructed by the NGO, which provides clean water food, shelter, healthcare and education for millions of Syrians.

According to the technology company, their donation is one of the charity’s largest ever single donor contributions.

The new village is set to accommodate 750 families, offering newly constructed homes, each featuring two bedrooms, a kitchen, and a bathroom.

The medical center, designed to serve 4,000 vulnerable individuals, will include a pharmacy and offer a comprehensive range of healthcare services, including clinics specializing in gynaecology, internal medicine, paediatrics, dentistry, physiotherapy, radiography, and pharmacy.

An artists impression of the new health centre

An artist’s impression of the new health centre 

Invatech Health’s CEO Tariq Muhammad was part of the delegation of four UK pharmacists, who recently visited the region on a four-day trip organised by the charity.

Tariq said that he saw firsthand the plight and suffering of thousands of people, mostly children, whose lives have been devastated by a decade-long civil war.

“My visit to Syria was a humbling experience and I was not prepared for what I saw,” he said.

“There were thousands of people living in squalid conditions with hardly any food or clean water. I visited a campsite where I saw children sitting in stagnant water. I sat in a tent where the father told me he burns bits of plastic to generate heat for his family.

“Having seen first-hand the suffering of so many people and the impact Action for Humanity is making, I felt compelled to help. For many it may seem only a drop in the ocean but every contribution we can make can change the lives of desperate people.

“As a pharmacist, I wanted to support the healthcare provision in the village as I have witnessed the amazing work doctors, nurses and pharmacists are already doing," he added.

The pharmacy tech entrepreneur has appealed to other UK business owners to help raise a further £125,000 to fund 50 homes in the new village and help those in desperate need in Syria.

“I hope that the business community will support me to help raise funds for the 50 houses. If 50 businesses can pay for one house each that would be incredible, but any amount is greatly appreciated and will contribute to the whole project,” he said.

Tariq has pledged to personally oversee the allocation of funds, ensuring that every donated penny contributes to the financing of the new village.

The village project is scheduled to start in the next couple of months and Tariq will be visiting Syria again later this year to check the progress.

Since the Syrian conflict started in March 2011, more than six million people have been displaced, with more than one million currently residing in tents. The tragedy escalated last year due to an earthquake in neighboring Turkey which destroyed even more homes across the region.

Jacob Marais, spokesman for Action for Humanity, said: “Thirteen years of suffering brought about by war, has been compounded by last year’s earthquake to create one of the worst humanitarian disasters in memory.

“A year on from the devastation and communities are still reeling. More than ever, Syrians need healthcare, housing, and support to ensure their long-term resilience.

“Following last year's earthquake, over 12 million people in Syria are in desperate need of medical assistance. The funds from Tariq's generous donation will go towards providing life-saving medical support to thousands of families in Northwest Syria."

During his trip to Syria, Tariq was accompanied by fellow pharmacist Zeshan Rehmani, who has been a leading advocate for Action For Humanity for many years supporting important humanitarian causes in war-stricken areas.

Zeshan’s Manchester Pharmacy and Health Clinic was an early adopter of the Titan patient medication record (PMR) system which was pioneered by Invatech Health.

To contribute to Tariq's Syria Appeal, please visit the Invatech Health's website.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less